WHOOP has been quiet on the women’s health side for a while. The platform’s core (strain scoring, HRV recovery, sleep debt) was designed around athletic performance, full stop. Gender-neutral by default, which in practice often means optimized for male training patterns.

That changed March 10, 2026. WHOOP shipped two new features: AI-powered Hormonal Symptom Insights and an upcoming Women’s Health Specialized Blood Biomarker Panel. One is live now in the app. One costs $299 and launches in April.

Here’s what both features actually do, what the limitations are, and whether they’re worth paying attention to.

Quick Verdict

Feature	Status	Cost
Hormonal Symptom Insights	Live now (app update)	Included in all tiers
Women’s Health Blood Panel	April 2026 (US only)	$299 one-time
Device compatibility	WHOOP 5.0 and WHOOP MG	Same hardware requirements

Best for: Female athletes who’ve noticed their training readiness and recovery scores vary across the month with no clear explanation Skip the blood panel if: You’ve had hormonal labs done recently or you’re pre-menopausal with no transition symptoms Subscription required: Yes—all tiers can access Hormonal Insights; blood panel is a separate purchase

What Hormonal Symptom Insights Does

This is the feature that went live March 10. It’s software, running on data you’re already generating.

WHOOP’s AI maps your logged symptoms and menstrual cycle data against your existing biometrics (HRV, skin temperature, resting heart rate, sleep quality) and builds a predictive model for your individual cycle windows. Over time it identifies symptom patterns (fatigue, mood shifts, pain, disrupted sleep) and correlates them with cycle phase.

The output is practical: predicted cycle windows, expected symptom timing, variability in period length and cycle length flagged when it deviates from your personal baseline.

The key word is personalized. This isn’t average population data applied to your cycle. WHOOP builds the model from your data. That matters because hormonal variability is enormous between individuals. “Luteal phase fatigue” isn’t a universal experience with universal timing. The feature is designed to learn when yours shows up specifically.

What this helps with: Training periodization. If WHOOP can tell you that your HRV typically drops 15% and your sleep quality degrades in the 4-5 days before menstruation, you can program your hardest training weeks around that rather than fighting a physiological headwind. Athletes who’ve spent years wondering why some weeks their performance tanks for no obvious reason now have a data-backed hypothesis to work with.

What it doesn’t do: Replace cycle tracking apps. WHOOP isn’t building period tracking from scratch. If you’re using Natural Cycles or Clue for contraception or fertility, this doesn’t substitute. Hormonal Insight is about training and recovery implications, not cycle management in the traditional sense.

Cycle Variability Flagging

Buried in the feature but potentially the most clinically relevant piece: WHOOP flags when your cycle length variability sits outside your personal normal range.

Significant cycle variability (changes of 7+ days, irregular cycles) can indicate training overload, underfueling, or thyroid dysfunction. For serious female athletes, this is a real concern. Relative energy deficiency in sport (RED-S) frequently shows up first as menstrual irregularities. An algorithm that notices your cycle shifting when your training load is climbing is catching something meaningful.

This isn’t diagnostic. WHOOP will tell you the pattern; it won’t tell you what’s causing it. But for athletes who train hard enough to affect hormonal function, seeing that flag in context with your strain history is more actionable than noticing it in isolation.

The Women’s Health Blood Biomarker Panel ($299)

This one doesn’t exist yet. It launches April 2026, US only.

The panel covers 11 biomarkers specifically selected for female hormonal health:

Hormonal transitions: Estrogen, progesterone, FSH, LH, testosterone Perimenopause indicators: The specific panel hasn’t been fully itemized publicly yet, but FSH levels are central to identifying perimenopause onset Thyroid: TSH, free T4 (or similar; exact composition pending final launch docs) Bone-metabolic resilience: Vitamin D, calcium metabolism markers

WHOOP’s framing is that the results integrate with your wearable data. Your blood panel results show up alongside your HRV trends, sleep patterns, and cycle data. The goal is context: a low HRV reading means something different if you also have a TSH value indicating subclinical hypothyroidism.

Is $299 a good price?

Honest benchmark: a standard hormonal panel through a primary care doctor, covered by insurance, costs you a copay. Out of pocket at a lab like Quest Diagnostics or LabCorp, a comparable hormone panel runs $150-400 depending on what’s included. A full thyroid panel alone is $100-200 out of pocket.

WHOOP’s $299 panel is competitive for what it covers if you don’t have good insurance coverage for labs, or if you’d rather not navigate a doctor’s referral for something that isn’t symptomatic. For women already tracking with WHOOP who want their lab results to live in the same data ecosystem, the integration has genuine value.

The friction case: If you have a gynecologist or internist who already orders labs, the $299 might be redundant. WHOOP isn’t a medical provider, so the panel comes with health coaching support but not prescriptions, treatment recommendations, or follow-up care. You’d still need a provider for any clinical action the results might indicate.

WHOOP 5.0 vs. WHOOP MG: Which Hardware Do You Need?

Both WHOOP 5.0 and WHOOP MG support all the new women’s health features. The hardware differentiation (ECG and blood pressure trend monitoring on the MG) doesn’t change here.

For a breakdown of whether the $359/year WHOOP MG tier is worth the premium over WHOOP One at $199/year, the WHOOP 5.0 vs. WHOOP MG review covers that in detail. Short version: the MG’s value case is cardiovascular monitoring for people with specific clinical reasons to want it, not general wellness upgrade.

For hormonal health features, WHOOP One at $199/year gives you everything the new March 10 update added.

What the Research Actually Says About Cycle-Aware Training

The idea that training performance varies across the menstrual cycle has solid grounding. A 2021 meta-analysis in Sports Medicine found that strength and neuromuscular performance tend to be highest in the follicular phase (roughly days 1-14) and lower in the luteal phase. Aerobic threshold performance shows similar patterns.

The practical problem has always been individual variability. The aggregate data says one thing; your specific hormonal profile, training status, and menstrual characteristics say another. What WHOOP is trying to solve is the personalization layer on top of the population-level research.

Whether the AI feature delivers on that promise is too early to evaluate. The model improves over time as it accumulates your data. Users who’ve worn WHOOP for 12+ months will see more sophisticated predictions than someone starting fresh.

That’s the honest limitation. Data from the first two or three cycles won’t produce the same quality insights as six or twelve months of logged data.

How This Compares to What Competitors Offer

Apple Watch (watchOS 26): The Cycle Tracking app in Apple Health syncs with WHOOP data for some users, but Apple’s predictive features are less performance-focused. Apple Project Mulberry is building toward more personalized health coaching but hasn’t shipped the cycle-specific training integration yet. See the Apple Project Mulberry AI health coach coverage for where that’s heading.

Oura Ring 4: Oura has had cycle insights integrated into its app for longer than WHOOP. The Readiness Score already factors in menstrual phase if you sync cycle data. Oura’s cycle-aware training suggestions are further developed than WHOOP’s new feature, though WHOOP’s athletic performance focus gives it an edge for serious training periodization.

Garmin: Basic menstrual cycle logging is in Garmin Connect, but it’s not algorithmically integrated with performance metrics in any meaningful way. No competitive threat here.

WHOOP’s differentiator is the training-load context. No other wearable is combining strain-based athletic tracking with cycle-phase correlation at this level yet. Whether the execution matches the concept is something we’ll evaluate after more time with it.

Who Should Use the Hormonal Insights Feature

Female athletes with unexplained performance variability across the month. If your worst training days follow a pattern you’ve never been able to attribute to sleep, stress, or workload alone, this is the feature to test. Give it 60-90 days to build a useful model. If you’re also evaluating how much sleep tracking data to trust from your wearable, the best sleep tracking apps guide covers what each device actually measures accurately.

Athletes in heavy training blocks. The cycle variability flagging is particularly relevant when you’re pushing volume. If your cycle length starts shifting during a high-mileage or high-intensity phase, that’s RED-S or cortisol-driven disruption to watch for.

Women approaching or in perimenopause. WHOOP’s framing specifically includes perimenopause as a supported transition period. The symptom pattern tracking has different but equally valid utility here. Menopause transition timelines are unpredictable, and having HRV and sleep data correlated against symptom logs could clarify a confusing period of physiological change.

Who Can Skip the Blood Panel

The $299 panel makes sense for specific people. It’s less obvious for others.

Skip it if: You’ve had a full hormonal workup in the last 12 months and your levels were unremarkable. Also skip it if you have an existing endocrinologist or gynecologist managing your hormonal health. Add another lab result to your chart through them instead.

Consider it if: You’re 40+ and haven’t had baseline labs done recently. Also consider it if you’ve been experiencing symptoms (fatigue, temperature dysregulation, sleep disruption, cycle changes) that haven’t been investigated. Having baseline thyroid, hormone, and vitamin D data living alongside your WHOOP tracking data could accelerate a productive conversation with a provider.

For context on how FDA rules around health claims for wearable lab panels are evolving, the FDA fitness wearable rules breakdown for 2026 covers the regulatory territory this kind of product sits in.

The Bottom Line

The Hormonal Symptom Insights feature is the more immediately impactful launch. It’s included in your existing subscription, it starts working with data you already have, and it addresses a real gap in how WHOOP has handled female physiology. Athletes who’ve been using WHOOP for years without good explanations for cyclical performance variation now have a tool designed specifically for that problem.

Give it three months before judging it. The AI model gets better with more data points.

The $299 blood panel launching in April is harder to evaluate without seeing the final implementation. The price is competitive. The integration concept is smart: lab results contextualized within your training and recovery history are genuinely more useful than results in isolation. But it’s a standalone purchase with no follow-up care built in, which means the actionability depends on what you do with the results.

If you already have good insurance and a proactive provider, the value case is thinner. If you’re paying out of pocket for labs anyway and you’re a WHOOP subscriber, $299 for an 11-biomarker panel integrated into your health dashboard is a reasonable call.

What’s clear: WHOOP is finally treating female athletic physiology as a primary use case rather than an afterthought. That’s late, but it’s the right direction.

---

Hormonal Symptom Insights evaluated based on March 2026 feature launch. Blood Biomarker Panel launches April 2026; full review pending after launch. Both features available on WHOOP 5.0 and WHOOP MG across all subscription tiers.